Recent FDA approval of suzetrigine, representing the first new class of pain medication in more than 20 years, is generating excitement among workers’ compensation professionals who have long been looking for a viable alternative to opioids. Suzetrigine is an oral …
Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the drugmaker over the launch of a biosimilar to Stelara, J&J’s autoimmune drug. J&J said it is seeking a preliminary …
Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant. Lawyers for a Los Angeles woman will argue Monday that …
The Sackler family, owners of Purdue Pharma, is offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure to future litigation, the Wall Street Journal reported on Monday. Some family members who …
Kroger has agreed to pay $110 million to resolve a lawsuit by the state of Kentucky alleging the supermarket chain’s pharmacies helped fuel a deadly opioid epidemic by flooding its communities with hundreds of millions of doses of addictive painkillers. …
McKinsey & Co. has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to boost sales. McKinsey has entered into a five-year …
McKinsey & Co. is in the final stages of negotiating a deferred prosecution agreement to resolve a U.S. criminal investigation into the consulting firm’s work helping opioid manufacturers boost sales that allegedly contributed to a deadly addiction epidemic, people familiar …
Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a federal judge abruptly dismissed an earlier version of the case. The …
GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen. The cases represent about 93% of those …
The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of collaborating to inflate the cost of insulin. Texas Attorney General Ken Paxton’s office said on Thursday it had sued insulin makers Eli Lilly, …